Upload
antonia-gregory
View
218
Download
0
Tags:
Embed Size (px)
Citation preview
59 y.o. F who presented with bilateral lower extremity weakness
PMH: • widely metastatic breast CA diagnosed in 2009
(Her2-, ER+, PR+)• s/p paclitaxel, bevacizumab, and letrozole• recurred in 2010, s/p gemcitabine• disease progression, s/p capecitabine +
zometa• disease progression, s/p radiation to lumbar
spine and hip• PE in 2011 on lovenox
Meds:• Zometa, Lovenox, Xeloda
Examination
Diffuse bilateral lower extremity weakness at 4/5
Imaging
Differential for lower extremity weakness
• cerebral (compression of bilateral ACA)• Spinal – Metabolic (B12, lipomatosis)– Vascular (hematoma, AVM)– Infectious(abscess, AIDs, TB, syphilis)– Trauma – Congenital (ALS, GBS, CIDP, myopathyies, ATM,
MS)
Staging for breast cancer
Stage 0: carcinoma in situ: 99% 5 year survivalStage 1: < 2 cm carcinoma: 92% Stage 2: > 2 cm carcinoma, no nodal
involvement: 60-80%Stage 3: nodal involvement or large tumor: 40-
60%Stage 4: distal metastasis: 14%
RPA classification
Surgical approach
Anatomic considerations• Motor strip• Cortical veins• ACA• Extent of retraction• Air embolus
Anesthesia considerations• Brain relaxation• Precordial doppler• Centeral line
Pre-operative assessment• Oncologic history• IVC, discontinue filter
Air embolus
• Tachycardia• Drop in end title CO2• Hypotension
Maneuver• Flood the field, drop the head, jugular compression,
terminate surgery• Stop nitrous oxide, ventilate with 100% O2• Central line suction, left side down
Cerebral swelling
• Identify source• Position: head up, release neck strain• ICP maneuvers: hyperventilate, mannitol, lasix,
EVD• Craniectomy• Lobectomy• Pentobarb coma (10 mg/kg over 30 minutes, 5
mg/kg q 1 hr x 3 hrs, 1 mg/kg/hr), titrate <5 mg% or EEG flattening.